Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Amortization of Deferred Charges (2019 - 2025)

Selectis Health's Amortization of Deferred Charges history spans 6 years, with the latest figure at $4184.0 for Q3 2025.

  • For Q3 2025, Amortization of Deferred Charges rose 10.86% year-over-year to $4184.0; the TTM value through Sep 2025 reached $16328.0, down 84.32%, while the annual FY2024 figure was $103432.0, 70.26% down from the prior year.
  • Amortization of Deferred Charges for Q3 2025 was $4184.0 at Selectis Health, roughly flat from $4184.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $197290.0 in Q2 2023 and bottomed at $3774.0 in Q3 2024.
  • The 4-year median for Amortization of Deferred Charges is $25304.5 (2021), against an average of $44361.3.
  • The largest annual shift saw Amortization of Deferred Charges surged 89.24% in 2021 before it tumbled 94.76% in 2025.
  • A 4-year view of Amortization of Deferred Charges shows it stood at $87700.0 in 2021, then tumbled by 94.92% to $4457.0 in 2023, then dropped by 15.28% to $3776.0 in 2024, then increased by 10.81% to $4184.0 in 2025.
  • Per Business Quant, the three most recent readings for GBCS's Amortization of Deferred Charges are $4184.0 (Q3 2025), $4184.0 (Q2 2025), and $4184.0 (Q1 2025).